Stockholders' Equity - Schedule of Changes in Equity (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	$ 966	$ (2,137)	$ (2,106)	$ (2,370)	$ (2,521)	$ (2,524)	$ (2,106)	$ (2,524)
Settlement of liability awards and other, net			43
Vesting of RSUs, net of tax withholdings and other	(3)	0	(31)	(3)	(4)	(13)
Purchase of treasury stock		(152)	(51)
Purchase of SciPlay common stock	(11)	(7)
Stock-based compensation	14	15	17	22	31	17
Net income	335	3,295	28	187	113	(9)	3,658	291
Other comprehensive loss	(69)	(48)	(37)	(27)	11	8
Stockholders' equity, ending balance	1,232	966	(2,137)	(2,191)	(2,370)	(2,521)	1,232	(2,191)
Net income attributable to L&W	328			182			3,645	276
Less: Net income attributable to noncontrolling interest	7			5			13	15
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	1	1	1	1	1	1	1	1
Stockholders' equity, ending balance	1	1	1	1	1	1	1	1
Additional Paid in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	1,375	1,366	1,337	1,299	1,272	1,268	1,337	1,268
Settlement of liability awards and other, net			43
Vesting of RSUs, net of tax withholdings and other	(3)	0	(31)	(3)	(4)	(13)
Purchase of SciPlay common stock	10	6
Stock-based compensation	14	15	17	22	31	17
Stockholders' equity, ending balance	1,376	1,375	1,366	1,318	1,299	1,272	1,376	1,318
Retained Earnings (Accumulated Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	159	(3,132)	(3,158)	(3,435)	(3,544)	(3,529)	(3,158)	(3,529)
Net income	328	3,291	26		109	(15)
Stockholders' equity, ending balance	487	159	(3,132)	(3,253)	(3,435)	(3,544)	487	(3,253)
Net income attributable to L&W				182
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	(378)	(226)	(175)	(175)	(175)	(175)	(175)	(175)
Purchase of treasury stock		(152)	(51)
Stockholders' equity, ending balance	(378)	(378)	(226)	(175)	(175)	(175)	(378)	(175)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	(346)	(298)	(261)	(199)	(210)	(218)	(261)	(218)
Other comprehensive loss	(69)	(48)	(37)	(27)	11	8
Stockholders' equity, ending balance	(415)	(346)	(298)	(226)	(199)	(210)	(415)	(226)
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	155	152	150	139	135	129	150	129
Purchase of SciPlay common stock	(1)	(1)
Stock-based compensation				0
Net income	7	4	2		4	6
Stockholders' equity, ending balance	161	$ 155	$ 152	144	$ 139	$ 135	161	$ 144
Less: Net income attributable to noncontrolling interest				$ 5
Discontinued Operations, Disposed of by Sale
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	$ 51						$ 74